Login / Signup

Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety.

Hannah PatrickKarthik RamasamySabia Rashid
Published in: European journal of haematology (2022)
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • stem cell transplantation
  • risk factors
  • adverse drug
  • chronic lymphocytic leukemia
  • drug induced
  • low dose